Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-shot protocol trial comparing sequential corifollitropin alfa versus corifollitropin alfa followed by recombinant FSH for elective fertility preservation
2023-506162-31-00Phase 3Completed
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in infertility comparing Sequential two-shot corifollitropin alfa protocol with Corifollitropin alfa followed by daily recombinant FSH (2 arms). Primary endpoint: Number of metaphase II oocytes retrieved. Started Dec 2023; status: completed.
02
Drugs
corifollitropin alfafollitropin beta
03
Conditions
infertility
Beyond the preview
Go deeper on 2023-506162-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506162-31-00.